| NDC Code | 70461-418-10 |
|---|
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (70461-418-10) > 5 mL in 1 VIAL, MULTI-DOSE (70461-418-11) |
|---|
| Product NDC | 70461-418 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Flucelvax Quadrivalent (multi-dose Vial) |
|---|
| Non-Proprietary Name | Influenza A Virus A/singapore/gp1908/2015 Ivr-180 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza A Virus A/north Carolina/04/2016 (h3n2) Hemagglutinin Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/iowa/06/2017 Hemagglutinin Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/singapore/inftt-16-0610/2016 Hemagglutinin Antigen (mdck Cell Derived, Propiolactone Inactivated) |
|---|
| Dosage Form | INJECTION, SUSPENSION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20160523 |
|---|
| End Marketing Date | 20190731 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125408 |
|---|
| Manufacturer | Seqirus, Inc. |
|---|
| Substance Name | INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/NORTH CAROLINA/04/2016 (H3N2) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/IOWA/06/2017 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) |
|---|
| Strength | 15; 15; 15; 15 |
|---|
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
|---|